We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Prostate Brachytherapy Causes Less Side Effects than Surgery

By HospiMedica staff writers
Posted on 12 Mar 2007
Men with prostate cancer have a slightly better long-term side-effects profile with radiation seed implants than they do with surgery, according to new research.

The study, published February 28, 2007, in the International Journal for Radiation Oncology*Biology*Physics, reported that clinicians in France conducted the first-ever multi-institutional, comparative study of men with early stage prostate cancer to evaluate a man's quality of life, treatment-related side effects, and cost of treatment based on the type of treatment the patient received: surgery or seed implants, both widely used modes of treatment for early-stage prostate cancer. More...
With prostate surgery, called a radical prostatectomy, a surgeon removes the prostate. During prostate brachytherapy, a radiation oncologist places radioactive seeds, similar to the size of a grain of rice, into the prostate to destroy the cancer.

In this study, conducted by investigators from the Institut Curie (Paris, France), 435 men with prostate cancer were surveyed before treatment, immediately after treatment, and subsequently at follow-up exams to assess their quality of life and treatment-related side effects against predefined materials given to them by the clinicians. The clinicians discovered that brachytherapy is a more costly procedure at the beginning, but that follow-up costs related to surgery cause both treatments to cost approximately the same.

Surgery had more significant side effects immediately following treatment, but those effects improved steadily over two years. Brachytherapy, however, demonstrated moderate, but persistent side effects over the two years. Urinary incontinence was more common after surgery; however, urinary irritation was a more typical complaint from those who received brachytherapy. Impairment of sexual function was found to be consistently higher among those who received surgery than those who received brachytherapy.

"This study is exciting because it's the first time we have a comparative study to assess the costs in a given country and see if the side effects are different for patients who received surgery or brachytherapy,” said Jean-Marc Cosset, M.D., one of the investigators of the study, and a radiation oncologist in the department of radiation oncology at the Institut Curie. "By looking at these factors, we are better able to tailor a suitable treatment option for the individual patient.”


Related Links:
Institut Curie

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
LED Surgical Lamp
ACEMST35/57
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.